Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1041-1050 of 1772 for

Edit search filters
  1. A Study Using Contrast Enhanced Digital Mammography In Addition To Diagnostic Mammography And Ultrasound For Suspicious Breast Lesions To Decrease Biopsy Rates

    Scottsdale/Phoenix, AZ

  2. Wild-Type Reovirus In Combination With Sargramostim In Treating Younger Patients With High-Grade Relapsed Or Refractory Brain Tumors

    Rochester, MN

  3. Pharmacokinetic Guided Dose Escalation And Dose Confirmation With Oral Decitabine And Oral CDAi In Patients With MDS

    Scottsdale/Phoenix, AZ

  4. A Study To Test The Addition Of Nivolumab To Chemotherapy To Treat Soft Tissue Sarcoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Gemcitabine Plus Cisplatin With Or Without Bintrafusp Alfa (M7824) In Participants With 1L Biliary Tract Cancer (BTC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. LS138D, Rituximab With Or Without Yttrium Y-90 Ibritumomab Tiuxetan In Treating Patients With Untreated Follicular Lymphoma

    Rochester, MN

  7. Metformin Hydrochloride And Combination Chemotherapy In Treating Patients With Stage III-IV Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer

    Rochester, MN

  8. Phase 3 Frontline Therapy Trial In Patients With Advanced Classical Hodgkin Lymphoma

    Rochester, MN

  9. Dose-Escalated Photon IMRT Or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy And Temozolomide In Treating Patients With Newly Diagnosed Glioblastoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

    Rochester, MN

.

Mayo Clinic Footer